Observational studyEuropean journal of pediatrics2026
Clinical utility of the Pediatric Bowel Management Scoring Tool in guiding management of childhood constipation-a prospective, multicenter study.
Observational study in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To evaluate the clinical utility of the Pediatric Bowel Management Scoring Tool (PBMST) by assessing its association with healthcare practitioner (HCP) treatment decisions and patient-reported quality of life in children with constipation using transanal irrigation (TAI). A multicenter prospective cohort study was conducted in 121 children (4-18 years) with functional or organic constipation, either newly initiating (NTP) or currently receiving (CTP) TAI. The PBMST and PedsQL™ 4.0 quality of life questionnaires were completed at baseline and one-month follow-up. PBMST outcomes range from 0 to 22; higher scores indicate worse bowel management. HCPs, blinded to PBMST scores, classified treatment strategies as adequate, sub-optimal, or inadequate. Associations between PBMST scores and HCP treatment decisions were analyzed using multiple linear regression, adjusting for age, sex, and participant type (NTP or CTP). Correlations between PBMST and PedsQL™ scores, as well as associations between TAI adherence, duration of TAI use, and predictors of high adherence (MARS-5 ≥ 23), were examined. Survey completion rates were 93% at baseline and 88% at follow-up. Higher PBMST scores were associated with HCP-rated inadequate treatment (B = 2.44, SE = 0.72, p = 0.001), independent of age, sex, and participant type (NTP or CTP). PBMST scores were negatively correlated with PedsQL™ scores (r = - 0.47, p < 0.001). No significant associations were found between adherence and TAI duration or PBMST scores. Lower adherence to TAI was associated with older age and participants reporting that TAI was too time-consuming.Conclusion: The PBMST is a valid tool reflecting symptom severity, correlating with HCP treatment decisions and patient-reported quality of life in children with functional or organic constipation using TAI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.